Skip Nav Destination
Improving Access to High-Value, High-Cost Medicines: The Use of Subscription Models to Treat Hepatitis C Using Direct-Acting Antivirals in the United States
J Health Polit Policy Law (2022) 47 (6): 691–708.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Julia M. Y. Pian
- Nana Owusu
- Julia Vitarello
- Winston X. Yan
- Andrew W. Lo
- Timothy W. Yu
Nature Medicine (2024) 30 (7): 1816.
- Nicola Schiano Moriello
- Biagio Pinchera
- Ivan Gentile
Expert Review of Anti-infective Therapy (2024) 22 (4): 139.
- Grace Hampson
- Lotte Steuten
Expert Review of Pharmacoeconomics & Outcomes Research (2024) 24 (1): 1.
- Johan L Dellgren
- Govind Persad
- Ezekiel J Emanuel
The Lancet (2024) 404 (10455): 902.
- Andrew H. Talal
- Arpan Dharia
- Shashi N. Kapadia
- Gia L. Tyson
- Susan Birch
- Judy Zerzan-Thul
- Donna Sullivan
- Elizabeth Britton
- Elaine Wethington
- Christopher J. Gonzalez
- Mary Fliss
- Brandon Mizroch
- Frederic McCall
- Audrey R. Lloyd
- Martin F. Shapiro
- Ricardo Franco
Journal of Public Health Management and Practice (2024) 30 (2): 208.
- J.I. Tsui
- A.J. Gojic
- K.A. Pierce
- E.L. Tung
- N.C. Connolly
- A.C. Radick
- R.R. Hunt
- R. Sandvold
- K. Taber
- M. Ninburg
- R.H. Kubiniec
- J.D. Scott
- R.N. Hansen
- J.D. Stekler
- E.J. Austin
- E.C. Williams
- S.N. Glick
Drug and Alcohol Dependence Reports (2024) 10: 100213.
- Laura Hawks
- Emily Wang
JAMA Health Forum (2023) 4 (4): e230167.
Hepatology (2023) 78 (2): 371.
